ArticleGenes & cancer2014

The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.

Lotte M E Berghauser Pont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.